Skip to content

Clinical Research Trials

Schiff Center for Liver Diseases

Global Department CTA Block

Research in hepatobiliary disease is becoming increasingly important as the American Association for the Study of Liver Diseases reports that 25 million Americans (1 in every 10) are afflicted with liver related diseases each year and 27,000 people die each year from chronic liver diseases.
  • Non-Alcoholic Fatty Liver Disease (NAFLD/NASH)

  • Primary Biliary Cholangitis (PBC) and Primary Sclerosing Cholangitis (PSC)

  • Viral Hepatitis and HIV

  • Additional Clinical Research Studies